Ercem Atillasoy - 19 Oct 2022 Form 4 Insider Report for Allovir, Inc. (KLRS)

Signature
/s/ Brett Hagen, as Attorney-in-Fact
Issuer symbol
KLRS
Transactions as of
19 Oct 2022
Net transactions value
-$18,272
Form type
4
Filing time
24 Oct 2022, 18:23:48 UTC
Previous filing
22 Jul 2022
Next filing
26 Oct 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALVR Common Stock Sale $5,317 -568 -0.43% $9.36 132,899 19 Oct 2022 Direct F1, F2
transaction ALVR Common Stock Sale $12,956 -1,527 -1.1% $8.48 131,372 20 Oct 2022 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units, and does not represent a discretionary trade by the Reporting Person.
F2 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $9.08 to $9.72. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
F3 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $8.40 to $8.61. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Remarks:

Officer Title: Chief Regulatory and Safety Officer